A Study to Evaluate the Safety and Tolerability of EP0089
NCT07030478
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
190
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Cancers
Solid Tumours
Interventions
DRUG:
EP0089-101
Sponsor
Ellipses Pharma